Tower Research Capital (TRC)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.9K | Sell |
|
|||||
|
2025
Q2 | $56.2K | Buy |
|
|||||
|
2025
Q1 | $24.5K | Sell |
|
|||||
|
2024
Q4 | $387K | Buy |
|
|||||
|
2024
Q3 | $106K | Sell |
|
|||||
|
2024
Q2 | $714K | Buy |
|
|||||
|
2024
Q1 | $3.6K | Sell |
|
|||||
|
2023
Q4 | $358K | Buy |
|
|||||
|
2023
Q3 | $80.9K | Buy |
|
|||||
|
2023
Q2 | $96K | Buy |
|
|||||
|
2023
Q1 | $62K | Buy |
|
|||||
|
2022
Q4 | $20K | Sell |
|
|||||
|
2022
Q3 | $616K | Buy |
|
|||||
|
2022
Q2 | $483K | Buy |
|
|||||
|
2022
Q1 | $241K | Buy |
|
|||||
|
2021
Q4 | $187K | Sell |
|
|||||
|
2021
Q3 | $298K | Buy |
|
|||||
|
2021
Q2 | $122K | Sell |
|
|||||
|
2021
Q1 | $144K | Buy |
|
|||||
|
2020
Q4 | $40K | Sell |
|
|||||
|
2020
Q3 | $46K | Sell |
|
|||||
|
2020
Q2 | $243K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $164K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $4K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $39K | Buy |
|
|||||
|
2017
Q4 | $9K | Sell |
|
|||||
|
2017
Q3 | $170K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $87K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $6K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $7K | Sell |
|
|||||
|
2015
Q2 | $267K | Buy |
|
|||||
|
2015
Q1 | $1K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $14K | Buy |
|
|||||
|
2014
Q2 | $8K | Sell |
|
|||||
|
2014
Q1 | $66K | Sell |
|
|||||
|
2013
Q4 | $432K | Buy |
|
|||||
|
2013
Q3 | $40K | Buy |
|